Literature DB >> 31700247

Transjugular intrahepatic portosystemic shunt via left hepatic - left portal veins.

Geert Maleux1.   

Abstract

Entities:  

Year:  2019        PMID: 31700247      PMCID: PMC6826072          DOI: 10.20524/aog.2019.0421

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


× No keyword cloud information.
A 38-year-old woman presented with recurrent upper gastrointestinal, variceal bleeding related to non-cirrhotic, portal hypertension associated with veno-occlusive liver disease. Her medical history also included Coats’ syndrome and end-stage renal disease. It was decided to create a transjugular intrahepatic portosystemic shunt (TIPS) to manage the recurrent upper variceal bleedings. However, since access to the right hepatic vein was impossible because of chronic proximal vein occlusion (Fig. 1), the patent’s left hepatic vein was cannulated. Puncture from the left hepatic vein into the left portal vein was successful (Fig. 2A) and, after tract balloon dilatation, an expanded tetrafluoroethylene-covered stent (Viatorr, W.L. Gore and Associates, Flagstaff, AZ, USA) was inserted and post-dilated up to 8 mm diameter (Fig. 2B). Post-interventional follow up showed no variceal bleeding episodes; however, the patient died 1 year later, following bradyarrhythmia and TIPS-induced hepatic encephalopathy.
Figure 1

Retrograde injection of iodinated contrast medium into the middle hepatic vein (small arrow) reveals opacification of many veno-venous collaterals and retrograde opacification of an accessory, subdiaphragmatic right hepatic vein (arrows), as well as opacification of the proximally occluded native right hepatic vein (large arrow)

Figure 2

(A) Insertion of the expanded tetrafluoroethylene-covered stent-graft (arrowheads) into the left portal vein through the left hepatic vein (arrow). (B) Completion of direct portography shows preferential flow through the fully patent transjugular intrahepatic portosystemic shunt, placed from the left portal vein up to the confluence of the inferior vena cava and the left hepatic vein

Retrograde injection of iodinated contrast medium into the middle hepatic vein (small arrow) reveals opacification of many veno-venous collaterals and retrograde opacification of an accessory, subdiaphragmatic right hepatic vein (arrows), as well as opacification of the proximally occluded native right hepatic vein (large arrow) (A) Insertion of the expanded tetrafluoroethylene-covered stent-graft (arrowheads) into the left portal vein through the left hepatic vein (arrow). (B) Completion of direct portography shows preferential flow through the fully patent transjugular intrahepatic portosystemic shunt, placed from the left portal vein up to the confluence of the inferior vena cava and the left hepatic vein Conventional TIPS procedures are performed by creating an intraparenchymal tract from the right hepatic vein into the right portal vein. They are associated with a very high success rate [1] related to the relatively large caliber and relatively close anatomical location of the 2 veins. However, in patients with a postoperative anatomy, including right hepatectomy [2] or left liver transplant recipients [3], creation of a TIPS can only be performed via the left hepatic vein. The presented case includes another pathological condition, namely chronic occlusion of the proximal right hepatic vein,
  3 in total

1.  Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations.

Authors:  Wael E A Saad; Mark G Davies; David E Lee; Nikhil C Patel; Lawrence G Sahler; Talia Sasson; Takashi Kitanososno; David L Waldman
Journal:  J Vasc Interv Radiol       Date:  2005-06       Impact factor: 3.464

2.  Placement of transjugular intrahepatic portosystemic shunt via the left hepatic vein under sonographic guidance in a patient with right hemihepatectomy.

Authors:  N Hidajat; M Kreuschner; R Röttgen; R-J Schröder; S Schmidt; R Felix
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

3.  Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: Long-term patency and clinical outcome results.

Authors:  Barbara Geeroms; Wim Laleman; Annouschka Laenen; Sam Heye; Chris Verslype; Schalk van der Merwe; Frederik Nevens; Geert Maleux
Journal:  Eur Radiol       Date:  2016-09-15       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.